Literature DB >> 24444074

Design and synthesis of a new class of 4-aminoquinolinyl- and 9-anilinoacridinyl Schiff base hydrazones as potent antimalarial agents.

Moni Sharma1, Kuldeep Chauhan, Rajeev K Srivastava, Shiv V Singh, Kumkum Srivastava, Jitendra K Saxena, Sunil K Puri, Prem M S Chauhan.   

Abstract

A series of novel 4-aminoquinolinyl and 9-anilinoacridinyl Schiff base hydrazones have been synthesized and evaluated for their antimalarial activity. All compounds were evaluated in vitro for their antimalarial activity against chloroquine-sensitive strain 3D7 and the chloroquine-resistant K1 strain of Plasmodium falciparum and for cytotoxicity toward Vero cells. Compounds 17, 20, and 21 displayed good activity against the 3D7 strain with IC50 values ranging from 19.69 to 25.38 nm. Moreover, compounds 16, 17, 21, 24, 32, and 33 exhibited excellent activities (21.64-54.26 nm) against K1 strain and several compounds displayed β-hematin inhibitory activity, suggesting that they act on the heme crystallization process such as CQ. Compounds were also found to be non-toxic with good selectivity index.
© 2014 John Wiley & Sons A/S.

Entities:  

Keywords:  4-aminoquinoline; 9-anilinoacridine; Schiff base; antimalarial; oxalamide

Mesh:

Substances:

Year:  2014        PMID: 24444074     DOI: 10.1111/cbdd.12289

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  2 in total

1.  Design, synthesis, conformational and molecular docking study of some novel acyl hydrazone based molecular hybrids as antimalarial and antimicrobial agents.

Authors:  Parvin Kumar; Kulbir Kadyan; Meenakshi Duhan; Jayant Sindhu; Vineeta Singh; Baljeet Singh Saharan
Journal:  Chem Cent J       Date:  2017-11-14       Impact factor: 4.215

2.  Benzimidazole Schiff base derivatives: synthesis, characterization and antimicrobial activity.

Authors:  Thierry Youmbi Fonkui; Monisola Itohan Ikhile; Patrick Berka Njobeh; Derek Tantoh Ndinteh
Journal:  BMC Chem       Date:  2019-11-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.